Breaking News Instant updates and real-time market news.

AKRX

Akorn

$3.93

-0.01 (-0.25%)

08:27
01/09/19
01/09
08:27
01/09/19
08:27

Akorn drops 20% to $3.15 after disclosing FDA warning letter

AKRX Akorn
$3.93

-0.01 (-0.25%)

11/26/18
RBCM
11/26/18
NO CHANGE
RBCM
Sector Perform
Akorn gets FDA approval for generic Voltaren Gel, says RBC Capital
RBC Capital analyst Randall Stanicky said his "back and forth with management" at Akorn confirmed that the company received FDA approval for its generic version of Voltaren Gel, which the analyst notes represents the third ANDA approval from the company's Amityville facility since October. Stanicky, who continues to watch the company's ongoing litigation as well as its progress on the remediation of its Decatur and Somerset facilities, keeps a Sector Perform rating on Akorn shares.
11/27/18
PIPR
11/27/18
NO CHANGE
Target $9
PIPR
Overweight
Akorn approval an 'encouraging development,' says Piper Jaffray
Piper Jaffray analyst David Amsellem views Akorn's (AKRX) approval of its generic of Voltaren Gel as an "encouraging development." The news demonstrates that the company can execute on the approval of products on the more technically challenging end of the generics spectrum, Amsellem tells investors in a research note. The analyst believes Akorn is well positioned for "significant EBITDA recovery" over the next two years. He sees a "high likelihood" that the company in 2018 will have worked through the bulk of the erosion of key generics due to competition and a "relatively high" probability of meaningful cost reductions if it loses its appeal in its case against Fresenius (FSNUY). Amsellem reiterates an Overweight rating on Akorn with a $9 price target.
12/07/18
CHLM
12/07/18
NO CHANGE
Target $11
CHLM
Buy
Craig-Hallum maintains Buy rating, $11 target on Akorn after Fresenius ruling
Craig-Hallum analyst Matt Hewitt said the Delaware Supreme Court ruling in favor of Fresenius (FSNUY) ends any hopes that a merger with Akorn (AKRX) will still occur, which may be a disappointment to some investors. However, it has been his view since the first ruling was announced that Akorn should be valued on a standalone basis. Akorn currently has a large pipeline of higher margin generics and the company's low-cost manufacturing facility in India has been idled due to the terms of the Fresenius agreement, but is likely to be brought online sometime in FY19 or FY20, Hewitt tells investors. He keeps a Buy rating and $11 price target on Akorn shares, which are down $1.34, or 24%, to $4.25 in afternoon trading.
12/10/18
PIPR
12/10/18
NO CHANGE
Target $9
PIPR
Overweight
Piper does not view Akorn as 'major fixer-upper,' keeps $9 target
Piper Jaffray analyst David Amsellem says he would not view Akorn (AKRX) as a "major fixer-upper" now that it is planning to move forward as a stand-alone company. Much of the pressure on EBITDA in recent years was a function of limited-competition products with brand-like margins, Amsellem tells investors in a research note. Further, the rest of Akorn's product portfolio appears to be stable, says the analyst. In addition, "high-quality" abbreviated new drug application approvals have been happening, "and that matters," argues Amsellem. He keeps an Overweight rating on Akorn with a $9 price target.

TODAY'S FREE FLY STORIES

EVTC

Evertec

$30.67

0.32 (1.05%)

16:13
02/20/19
02/20
16:13
02/20/19
16:13
Earnings
Breaking Earnings news story on Evertec »

Evertec reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 27

    Feb

  • 12

    Mar

  • 22

    May

LOPE

Grand Canyon

$97.13

0.18 (0.19%)

16:13
02/20/19
02/20
16:13
02/20/19
16:13
Earnings
Grand Canyon sees FY19 EPS $5.10, consenus $5.06 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

MMI

Marcus & Millichap

$38.88

-0.68 (-1.72%)

16:13
02/20/19
02/20
16:13
02/20/19
16:13
Earnings
Marcus & Millichap reports Q4 EPS 66c, consensus 53c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 11

    Apr

EXR

Extra Space Storage

$95.90

-3.18 (-3.21%)

16:12
02/20/19
02/20
16:12
02/20/19
16:12
Earnings
Extra Space Storage reports Q4 EPS 80c, consensus 76c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

EVTC

Evertec

$30.67

0.32 (1.05%)

16:12
02/20/19
02/20
16:12
02/20/19
16:12
Earnings
Evertec reports Q4 adjusted EPS 46c, consensus 44c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 27

    Feb

  • 12

    Mar

  • 22

    May

CBLK

Carbon Black

$16.50

0.16 (0.98%)

16:12
02/20/19
02/20
16:12
02/20/19
16:12
Earnings
Carbon Black sees FY19 EPS (64c)-(61c), consensus (70c) »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 04

    Mar

  • 05

    Mar

  • 13

    Mar

LOPE

Grand Canyon

$97.09

0.14 (0.14%)

16:11
02/20/19
02/20
16:11
02/20/19
16:11
Earnings
Grand Canyon sees Q1 EPS $1.49, consensus $1.40 »

Sees Q1 revenue $195.5M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

MANT

ManTech

$58.49

0.58 (1.00%)

16:11
02/20/19
02/20
16:11
02/20/19
16:11
Hot Stocks
ManTech increases quarterly dividend to 27c from 25c »

The company has increased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

ROG

Rogers Corporation

$136.53

1.23 (0.91%)

16:11
02/20/19
02/20
16:11
02/20/19
16:11
Hot Stocks
Breaking Hot Stocks news story on Rogers Corporation »

Rogers Corporation sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 07

    Mar

XPER

Xperi

$23.18

0.36 (1.58%)

16:11
02/20/19
02/20
16:11
02/20/19
16:11
Earnings
Breaking Earnings news story on Xperi »

Xperi sees Q1 billings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 27

    Mar

  • 28

    Mar

CBLK

Carbon Black

$16.50

0.16 (0.98%)

16:11
02/20/19
02/20
16:11
02/20/19
16:11
Earnings
Carbon Black sees Q1 EPS (23c)-(22c), consensus (21c) »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 04

    Mar

  • 05

    Mar

  • 13

    Mar

ROG

Rogers Corporation

$136.53

1.23 (0.91%)

16:11
02/20/19
02/20
16:11
02/20/19
16:11
Earnings
Rogers Corporation sees Q1 adjusted EPS $1.25-$1.40, consensus $1.42 »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 07

    Mar

XPER

Xperi

$23.18

0.36 (1.58%)

16:11
02/20/19
02/20
16:11
02/20/19
16:11
Earnings
Breaking Earnings news story on Xperi »

Xperi reports Q4 billings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 27

    Mar

  • 28

    Mar

AMSWA

American Software

$11.61

0.09 (0.78%)

16:10
02/20/19
02/20
16:10
02/20/19
16:10
Earnings
American Software reports Q3 adjusted EPS 10c, one estimate 4c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

ROG

Rogers Corporation

$136.52

1.22 (0.90%)

16:10
02/20/19
02/20
16:10
02/20/19
16:10
Earnings
Rogers Corporation reports Q4 adjusted EPS $1.67, consensus $1.27 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 07

    Mar

CBLK

Carbon Black

$16.54

0.2 (1.22%)

16:10
02/20/19
02/20
16:10
02/20/19
16:10
Earnings
Carbon Black reports Q4 EPS (20c), consensus (24c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 04

    Mar

  • 05

    Mar

  • 13

    Mar

LOPE

Grand Canyon

$97.03

0.08 (0.08%)

16:10
02/20/19
02/20
16:10
02/20/19
16:10
Earnings
Grand Canyon reports Q4 EPS $1.56, consensus $1.42 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

MANT

ManTech

$58.49

0.58 (1.00%)

16:10
02/20/19
02/20
16:10
02/20/19
16:10
Earnings
ManTech sees FY19 EPS $2.15-$2.28, consensus $2.32 »

Sees FY19 revenue $2.05B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

GDDY

GoDaddy

$72.30

-0.39 (-0.54%)

16:10
02/20/19
02/20
16:10
02/20/19
16:10
Hot Stocks
Breaking Hot Stocks news story on GoDaddy »

GoDaddy drops 2% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

GDOT

Green Dot

$74.60

-0.14 (-0.19%)

16:09
02/20/19
02/20
16:09
02/20/19
16:09
Earnings
Green Dot sees FY19 adjusted EPS $3.59-$3.67, consensus $3.62 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SITC

Site Centers

$12.98

-0.41 (-3.06%)

16:09
02/20/19
02/20
16:09
02/20/19
16:09
Earnings
Site Centers sees FY19 FFO $1.13-$1.18, consensus $1.16 »

Backs FY19 Same-store NOI…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

A

Agilent

$78.56

1.08 (1.39%)

16:09
02/20/19
02/20
16:09
02/20/19
16:09
Earnings
Agilent sees Q2 EPS 70c-72c, consensus 72c »

Sees Q2 revenue of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 27

    Feb

GDDY

GoDaddy

$72.29

-0.4 (-0.55%)

16:09
02/20/19
02/20
16:09
02/20/19
16:09
Earnings
Breaking Earnings news story on GoDaddy »

GoDaddy sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

VIPS

Vipshop

$7.31

0.36 (5.18%)

16:09
02/20/19
02/20
16:09
02/20/19
16:09
Earnings
Vipshop sees Q1 revenue growth 0%-5%, consensus $3.2B »

For the first quarter of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

GDOT

Green Dot

$74.68

-0.06 (-0.08%)

16:09
02/20/19
02/20
16:09
02/20/19
16:09
Earnings
Green Dot reports Q4 adjusted EPS 56c, consensus 50c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.